List of all referred studies

Abe, K., M. Okano, and H. Sasaki. "Phenytoin Elimination Kinetics in Two Children with Drug Intoxication." Eur J Pediatr 135, no. 1 (1980): 69-71.

Adityanjee. "The Syndrome of Irreversible Lithium-Effectuated Neurotoxicity (Silent)." Pharmacopsychiatry 22, no. 2 (1989): 81-3.

Adityanjee, K. R. Munshi, and A. Thampy. "The Syndrome of Irreversible Lithium-Effectuated Neurotoxicity." Clin Neuropharmacol 28, no. 1 (2005): 38-49.

Agrawal, B. L. "Ataxia Caused by Fluoxymesterone Therapy in Breast Cancer." Arch Intern Med 141, no. 7 (1981): 958-9.

Alioglu, Z., A. Sari, S. K. Velioglu, Ouml, and M. zmenoglu. "Cerebellar Atrophy Following Acute Phenytoin Intoxication." J Neuroradiol 27, no. 1 (2000): 52-5.

Alkawi, A., J. C. Kattah, and K. Wyman. "Downbeat Nystagmus as a Result of Lamotrigine Toxicity." Epilepsy Res 63, no. 2-3 (2005): 85-8.

Andrade, C., B. N. Gangadhar, and S. M. Channabasavanna. "Pathological Neurotoxicity with Lithium." Indian J Psychiatry 29, no. 3 (1987): 279-81.

Anhut, H., P. Ashman, T. J. Feuerstein, W. Sauermann, M. Saunders, and B. Schmidt. "Gabapentin (Neurontin) as Add-on Therapy in Patients with Partial Seizures: A Double-Blind, Placebo-Controlled Study. The International Gabapentin Study Group." Epilepsia 35, no. 4 (1994): 795-801.

Apte, S. N., and J. W. Langston. "Permanent Neurological Deficits Due to Lithium Toxicity." Ann Neurol 13, no. 4 (1983): 453-5.

Ardalan, B., G. Singh, and H. Silberman. "A Randomized Phase I and Ii Study of Short-Term Infusion of High-Dose Fluorouracil with or without N-(Phosphonacetyl)-L-Aspartic Acid in Patients with Advanced Pancreatic and Colorectal Cancers." J Clin Oncol 6, no. 6 (1988): 1053-8.

Arezzo, J. C., J. Rosenstock, L. Lamoreaux, and L. Pauer. "Efficacy and Safety of Pregabalin 600 Mg/D for Treating Painful Diabetic Peripheral Neuropathy: A Double-Blind Placebo-Controlled Trial." BMC Neurol 8, (2008): 33.

Armour, D. J., C. Fidler, E. C. Wright, and S. Balarajan. "Vigabatrin in Adults with Poorly-Controlled Epilepsy and Learning Disabilities." Seizure 1, no. 3 (1992): 157-62.

Arroyo, S., H. Anhut, A. R. Kugler, C. M. Lee, L. E. Knapp, E. A. Garofalo, S. Messmer, and Group Pregabalin -011 International Study. "Pregabalin Add-on Treatment: A Randomized, Double-Blind, Placebo-Controlled, Dose-Response Study in Adults with Partial Seizures." Epilepsia 45, no. 1 (2004): 20-7.

Arya, D. K. "Lithium-Induced Neurotoxicity at Serum Lithium Levels within the Therapeutic Range." Aust N Z J Psychiatry 30, no. 6 (1996): 871-3.

Atkins, J. N., H. B. Muss, D. Case, J. Brockschmidt, F. M. Schnell, M. O'Rourke, T. H. Grote, J. H. West, S. Anthony, and V. Stanley. "High-Dose 24-Hour Infusion of 5-Fluorouracil in Metastatic Prostate Cancer. A Phase Ii Trial of the Piedmont Oncology Association." Am J Clin Oncol 14, no. 6 (1991): 526-9.

Atkinson, K., J. Biggs, P. Darveniza, J. Boland, A. Concannon, and A. Dodds. "Spinal Cord and Cerebellar-Like Syndromes Associated with the Use of Cyclosporine in Human Recipients of Allogeneic Marrow Transplants." Transplant Proc 17, no. 2 (1985): 1673-5.

Awada, A., P. Amene, M. al Jumah, and K. al Beladi. "[Residual Cerebellar Ataxia Following Acute Phenytoin Intoxication]." Rev Neurol (Paris) 155, no. 4 (1999): 306-8.

Aylett, S. E., H. Cross, and D. Berry. "Eye Rolling as a Manifestation of Clobazam Toxicity in a Child with Epilepsy." Dev Med Child Neurol 48, no. 7 (2006): 612-5.

Baath, N. S., J. Hong, and S. P. Sattar. "Possible Carbamazepine Toxicity with Terbinafine." Can J Clin Pharmacol 13, no. 2 (2006): e228-31.

Baier, W. K., U. Beck, H. Doose, H. Klinge, and W. Hirsch. "Cerebellar Atrophy Following Diphenylhydantoin Intoxication." Neuropediatrics 15, no. 2 (1984): 76-81.

Baier, W. K., U. Beck, and W. Hirsch. "Ct Findings Following Diphenylhydantoin Intoxication." Pediatr Radiol 15, no. 4 (1985): 220-1.

Barcs, G., E. B. Walker, C. E. Elger, A. Scaramelli, H. Stefan, Y. Sturm, A. Moore, G. Flesch, L. Kramer, and J. D'Souza. "Oxcarbazepine Placebo-Controlled, Dose-Ranging Trial in Refractory Partial Epilepsy." Epilepsia 41, no. 12 (2000): 1597-607.

Baulac, M., D. Cavalcanti, F. Semah, A. Arzimanoglou, and J. J. Portal. "Gabapentin Add-on Therapy with Adaptable Dosages in 610 Patients with Partial Epilepsy: An Open, Observational Study. The French Gabapentin Collaborative Group." Seizure 7, no. 1 (1998): 55-62.

Baulac, M., T. Leon, T. J. O'Brien, E. Whalen, and J. Barrett. "A Comparison of Pregabalin, Lamotrigine, and Placebo as Adjunctive Therapy in Patients with Refractory Partial-Onset Seizures." Epilepsy Res 91, no. 1 (2010): 10-9.

Baz, D. V., J. S. Bofill, and J. A. Nogueira. "Irinotecan-Induced Dysarthria." J Natl Cancer Inst 93, no. 18 (2001): 1419-20.

Beattie, B., J. Biller, B. Mehlhaus, and M. Murray. "Verapamil-Induced Carbamazepine Neurotoxicity. A Report of Two Cases." Eur Neurol 28, no. 2 (1988): 104-5.

Bechstein, W. O. "Neurotoxicity of Calcineurin Inhibitors: Impact and Clinical Management." Transpl Int 13, no. 5 (2000): 313-26.

Belli, L. S., L. De Carlis, F. Romani, G. F. Rondinara, P. Rimoldi, A. Alberti, G. Bettale, L. Dughetti, G. Ideo, M. Sberna, and et al. "Dysarthria and Cerebellar Ataxia: Late Occurrence of Severe Neurotoxicity in a Liver Transplant Recipient." Transpl Int 6, no. 3 (1993): 176-8.

Ben-Menachem, E., V. Biton, D. Jatuzis, B. Abou-Khalil, P. Doty, and G. D. Rudd. "Efficacy and Safety of Oral Lacosamide as Adjunctive Therapy in Adults with Partial-Onset Seizures." Epilepsia 48, no. 7 (2007): 1308-17.

Ben-Menachem, E., A. A. Gabbai, A. Hufnagel, J. Maia, L. Almeida, and P. Soares-da-Silva. "Eslicarbazepine Acetate as Adjunctive Therapy in Adult Patients with Partial Epilepsy." Epilepsy Res 89, no. 2-3 (2010): 278-85.

Ben-Menachem, E., O. Henriksen, M. Dam, M. Mikkelsen, D. Schmidt, S. Reid, R. Reife, L. Kramer, G. Pledger, and R. Karim. "Double-Blind, Placebo-Controlled Trial of Topiramate as Add-on Therapy in Patients with Refractory Partial Seizures." Epilepsia 37, no. 6 (1996): 539-43.

Bendiksen, A., and L. M. Larsen. "Convulsions, Ataxia and Hallucinations Following Propofol." Acta Anaesthesiol Scand 42, no. 6 (1998): 739-41.

Beran, R., S. Berkovic, A. Black, G. Danta, J. Dunne, J. Frasca, K. Grainger, C. Kilpatrick, R. McKenzie, D. McLaughlin, G. Schapel, and E. Somerville. "Australian Study of Titration to Effect Profile of Safety (Aus-Steps): High-Dose Gabapentin (Neurontin) in Partial Seizures." Epilepsia 42, no. 10 (2001): 1335-9.

Beran, R. G., S. F. Berkovic, N. Buchanan, G. Danta, R. Mackenzie, G. Schapel, G. Sheean, and F. Vajda. "A Double-Blind, Placebo-Controlled Crossover Study of Vigabatrin 2 G/Day and 3 G/Day in Uncontrolled Partial Seizures." Seizure 5, no. 4 (1996): 259-65.

Beran, R. G., S. F. Berkovic, F. M. Dunagan, F. J. Vajda, G. Danta, A. B. Black, and R. Mackenzie. "Double-Blind, Placebo-Controlled, Crossover Study of Lamotrigine in Treatment-Resistant Generalised Epilepsy." Epilepsia 39, no. 12 (1998): 1329-33.

Bernstein, A. L., and J. L. Leventhal-Rochon. "Neurotoxicity Related to the Use of Topical Tretinoin (Retin-a)." Ann Intern Med 124, no. 2 (1996): 227-8.

Betts, T., G. Goodwin, R. M. Withers, and A. W. Yuen. "Human Safety of Lamotrigine." Epilepsia 32 Suppl 2, (1991): S17-21.

Beydoun, A., B. M. Uthman, A. R. Kugler, M. J. Greiner, L. E. Knapp, E. A. Garofalo, and Group Pregabalin -009 Study. "Safety and Efficacy of Two Pregabalin Regimens for Add-on Treatment of Partial Epilepsy." Neurology 64, no. 3 (2005): 475-80.

Binnie, C. D., R. M. Debets, M. Engelsman, J. W. Meijer, H. Meinardi, J. Overweg, A. W. Peck, A. Van Wieringen, and W. C. Yuen. "Double-Blind Crossover Trial of Lamotrigine (Lamictal) as Add-on Therapy in Intractable Epilepsy." Epilepsy Res 4, no. 3 (1989): 222-9.

Binnie, C. D., W. van Emde Boas, D. G. Kasteleijn-Nolste-Trenite, R. A. de Korte, J. W. Meijer, H. Meinardi, A. A. Miller, J. Overweg, A. W. Peck, A. van Wieringen, and et al. "Acute Effects of Lamotrigine (Bw430c) in Persons with Epilepsy." Epilepsia 27, no. 3 (1986): 248-54.

Biton, V., A. Gil-Nagel, M. J. Brodie, S. E. Derossett, and V. Nohria. "Safety and Tolerability of Different Titration Rates of Retigabine (Ezogabine) in Patients with Partial-Onset Seizures." Epilepsy Res 107, no. 1-2 (2013): 138-45.

Blanche, P., E. Raynaud, D. Kerob, and N. Galezowski. "Lithium Intoxication in an Elderly Patient after Combined Treatment with Losartan." Eur J Clin Pharmacol 52, no. 6 (1997): 501.

Boas, J., M. Dam, M. L. Friis, O. Kristensen, B. Pedersen, and J. Gallagher. "Controlled Trial of Lamotrigine (Lamictal) for Treatment-Resistant Partial Seizures." Acta Neurol Scand 94, no. 4 (1996): 247-52.

Boesen, P., J. Fallingborg, and E. Spaun. "Severe Persistent Cerebellar Dysfunction Complicating Cytosine Arabinoside Therapy." Acta Med Scand 224, no. 2 (1988): 189-91.

Bollen, E., and J. B. Lanser. "Reversible Mental Deterioration and Neurological Disturbances with O,P'-Ddd Therapy." Clin Neurol Neurosurg 94 Suppl, (1992): S49-51.

Bos, M. J., A. W. de Weerd, and E. E. Hagebeuk. "[Staring Episodes in Children with Developmental Disorders: Epilepsy or Behaviour?]." Ned Tijdschr Geneeskd 155, (2011): A2473.

Bosso, J. A., C. A. Liptak, D. K. Seilheimer, and G. M. Harrison. "Toxicity of Colistin in Cystic Fibrosis Patients." DICP 25, no. 11 (1991): 1168-70.

Botez, M. I., J. Gravel, E. Attig, and J. L. Vezina. "Reversible Chronic Cerebellar Ataxia after Phenytoin Intoxication: Possible Role of Cerebellum in Cognitive Thought." Neurology 35, no. 8 (1985): 1152-7.

Brodie, M. J. "Lamotrigine--an Update." Can J Neurol Sci 23, no. 4 Suppl 2 (1996): S6-9.

Brodie, M. J., H. Lerche, A. Gil-Nagel, C. Elger, S. Hall, P. Shin, V. Nohria, H. Mansbach, and Restore Study Group. "Efficacy and Safety of Adjunctive Ezogabine (Retigabine) in Refractory Partial Epilepsy." Neurology 75, no. 20 (2010): 1817-24.

Browne, T. R., R. H. Mattson, J. K. Penry, D. B. Smith, D. M. Treiman, B. J. Wilder, E. Ben-Menachem, R. M. Miketta, K. M. Sherry, and G. K. Szabo. "A Multicentre Study of Vigabatrin for Drug-Resistant Epilepsy." Br J Clin Pharmacol 27 Suppl 1, (1989): 95S-100S.

Buckler, R. A., and J. H. Friedman. "Maprotiline-Induced Ataxia." J Clin Psychopharmacol 6, no. 6 (1986): 382-3.

Cachat, F., and A. Tufro. "Phenytoin/Isradipine Interaction Causing Severe Neurologic Toxicity." Ann Pharmacother 36, no. 9 (2002): 1399-402.

Cereghino, J. J., V. Biton, B. Abou-Khalil, F. Dreifuss, L. J. Gauer, and I. Leppik. "Levetiracetam for Partial Seizures: Results of a Double-Blind, Randomized Clinical Trial." Neurology 55, no. 2 (2000): 236-42.

Cerqueira, A. C., M. C. Reis, F. D. Novis, J. M. Bezerra, G. C. Magalhaes, M. Rozenthal, and A. E. Nardi. "Cerebellar Degeneration Secondary to Acute Lithium Carbonate Intoxication." Arq Neuropsiquiatr 66, no. 3A (2008): 578-80.

Chacko, J., K. Pramod, S. Sinha, J. Saini, A. Mahadevan, R. D. Bharath, P. S. Bindu, T. C. Yasha, and A. B. Taly. "Clinical, Neuroimaging and Pathological Features of 5-Nitroimidazole-Induced Encephalo-Neuropathy in Two Patients: Insights into Possible Pathogenesis." Neurol India 59, no. 5 (2011): 743-7.

Chan, K., and R. G. Beran. "Value of Therapeutic Drug Level Monitoring and Unbound (Free) Levels." Seizure 17, no. 6 (2008): 572-5.

Chappell, A. S., J. W. Sander, M. J. Brodie, D. Chadwick, A. Lledo, D. Zhang, J. Bjerke, G. M. Kiesler, and S. Arroyo. "A Crossover, Add-on Trial of Talampanel in Patients with Refractory Partial Seizures." Neurology 58, no. 11 (2002): 1680-2.

Charness, M. E., F. Morady, and M. M. Scheinman. "Frequent Neurologic Toxicity Associated with Amiodarone Therapy." Neurology 34, no. 5 (1984): 669-71.

Choi, J. Y., Y. M. Park, Y. S. Woo, S. U. Kim, J. M. Jung, and D. Y. Kwon. "Perverted Head-Shaking and Positional Downbeat Nystagmus in Pregabalin Intoxication." J Neurol Sci 337, no. 1-2 (2014): 243-4.

Chung, S., M. R. Sperling, V. Biton, G. Krauss, D. Hebert, G. D. Rudd, P. Doty, and S. P. Study Group. "Lacosamide as Adjunctive Therapy for Partial-Onset Seizures: A Randomized Controlled Trial." Epilepsia 51, no. 6 (2010): 958-67.

Cocito, L., M. Maffini, and C. Loeb. "Long-Term Observations on the Clinical Use of Lamotrigine as Add-on Drug in Patients with Epilepsy." Epilepsy Res 19, no. 2 (1994): 123-7.

Cocito, L., M. Maffini, P. Perfumo, F. Roncallo, and C. Loeb. "Vigabatrin in Complex Partial Seizures: A Long-Term Study." Epilepsy Res 3, no. 2 (1989): 160-6.

Cohen, W. J., and N. H. Cohen. "Lithium Carbonate, Haloperidol, and Irreversible Brain Damage." JAMA 230, no. 9 (1974): 1283-7.

Coldwell, S. E., K. Awamura, P. Milgrom, K. S. Depner, E. Kaufman, K. L. Preston, and H. W. Karl. "Side Effects of Triazolam in Children." Pediatr Dent 21, no. 1 (1999): 18-25.

Conners, G. P. "Piperazine Neurotoxicity: Worm Wobble Revisited." J Emerg Med 13, no. 3 (1995): 341-3.

Coulter, D. M., I. R. Edwards, and R. L. Savage. "Survey of Neurological Problems with Amiodarone in the New Zealand Intensive Medicines Monitoring Programme." N Z Med J 103, no. 885 (1990): 98-100.

Craig, S. "Phenytoin Poisoning." Neurocrit Care 3, no. 2 (2005): 161-70.

Crawford, P., H. Meinardi, S. Brown, T. W. Rentmeester, B. Pedersen, P. C. Pedersen, and L. C. Lassen. "Tiagabine: Efficacy and Safety in Adjunctive Treatment of Partial Seizures." Epilepsia 42, no. 4 (2001): 531-8.

Curtis, D. L., R. Piibe, M. J. Ellenhorn, J. Wasserberger, and G. Ordog. "Phenytoin Toxicity: A Review of 94 Cases." Vet Hum Toxicol 31, no. 2 (1989): 164-5.

Dallocchio, C., C. Buffa, P. Mazzarello, and S. Chiroli. "Gabapentin Vs. Amitriptyline in Painful Diabetic Neuropathy: An Open-Label Pilot Study." J Pain Symptom Manage 20, no. 4 (2000): 280-5.

De Marco, S., E. Squilloni, L. Vigna, M. F. Bertagnolio, and C. N. Sternberg. "Irinotecan Chemotherapy Associated with Transient Dysarthria and Aphasia." Ann Oncol 15, no. 7 (2004): 1147-8.

Dean, C., M. Mosier, and K. Penry. "Dose-Response Study of Vigabatrin as Add-on Therapy in Patients with Uncontrolled Complex Partial Seizures." Epilepsia 40, no. 1 (1999): 74-82.

Dembowski, C., and T. Rechlin. "Successful Antimanic Treatment and Mood Stabilization with Lamotrigine, Clozapine, and Valproate in a Bipolar Patient after Lithium-Induced Cerebellar Deterioration. A Case Report." Pharmacopsychiatry 36, no. 2 (2003): 83-6.

Dennison, U., M. Clarkson, J. O'Mullane, and E. M. Cassidy. "The Incidence and Clinical Correlates of Lithium Toxicity: A Retrospective Review." Ir J Med Sci 180, no. 3 (2011): 661-5.

Dixon, R. A., N. R. Bennett, M. J. Harrison, C. Kenyon, and J. A. Thornton. "I.V. Flunitrazepam and I.V. Diazepam in Conservative Dentistry. A Cross-over Trial." Br J Anaesth 52, no. 5 (1980): 517-26.

Donaldson, I. M., and J. Cuningham. "Persisting Neurologic Sequelae of Lithium Carbonate Therapy." Arch Neurol 40, no. 12 (1983): 747-51.

Dorado, P., E. Lopez-Torres, E. M. Penas-Lledo, J. Martinez-Anton, and A. Llerena. "Neurological Toxicity after Phenytoin Infusion in a Pediatric Patient with Epilepsy: Influence of Cyp2c9, Cyp2c19 and Abcb1 Genetic Polymorphisms." Pharmacogenomics J 13, no. 4 (2013): 359-61.

Dreifuss, F. E., J. K. Penry, S. W. Rose, H. J. Kupferberg, P. Dyken, and S. Sato. "Serum Clonazepam Concentrations in Children with Absence Seizures." Neurology 25, no. 3 (1975): 255-8.

Dubey, A. K., R. K. Gupta, and R. K. Sharma. "Levamisole Induced Ataxia." Indian Pediatr 38, no. 4 (2001): 417-9.

Duchowny, M., J. M. Pellock, W. D. Graf, C. Billard, J. Gilman, E. Casale, G. Womble, M. Risner, and P. Manasco. "A Placebo-Controlled Trial of Lamotrigine Add-on Therapy for Partial Seizures in Children. Lamictal Pediatric Partial Seizure Study Group." Neurology 53, no. 8 (1999): 1724-31.

Dworkin, L. A., R. D. Goldman, L. S. Zivin, and P. C. Fuchs. "Cerebellar Toxicity Following High-Dose Cytosine Arabinoside." J Clin Oncol 3, no. 5 (1985): 613-6.

Dworkin, R. H., A. E. Corbin, J. P. Young, Jr., U. Sharma, L. LaMoreaux, H. Bockbrader, E. A. Garofalo, and R. M. Poole. "Pregabalin for the Treatment of Postherpetic Neuralgia: A Randomized, Placebo-Controlled Trial." Neurology 60, no. 8 (2003): 1274-83.

Early, A. P., H. D. Preisler, H. Slocum, and Y. M. Rustum. "A Pilot Study of High-Dose 1-Beta-D-Arabinofuranosylcytosine for Acute Leukemia and Refractory Lymphoma: Clinical Response and Pharmacology." Cancer Res 42, no. 4 (1982): 1587-94.

Elger, C., M. Bialer, J. A. Cramer, J. Maia, L. Almeida, and P. Soares-da-Silva. "Eslicarbazepine Acetate: A Double-Blind, Add-on, Placebo-Controlled Exploratory Trial in Adult Patients with Partial-Onset Seizures." Epilepsia 48, no. 3 (2007): 497-504.

Elger, C. E., M. J. Brodie, H. Anhut, C. M. Lee, and J. A. Barrett. "Pregabalin Add-on Treatment in Patients with Partial Seizures: A Novel Evaluation of Flexible-Dose and Fixed-Dose Treatment in a Double-Blind, Placebo-Controlled Study." Epilepsia 46, no. 12 (2005): 1926-36.

Ellaway, C. J., B. Bennetts, R. R. Tuck, and B. Wilcken. "Clumsiness, Confusion, Coma, and Valproate." Lancet 353, no. 9162 (1999): 1408.

Ertan, S., M. O. Ulu, H. Hanimoglu, T. Tanriverdi, A. M. Kafadar, Z. U. Acar, and G. Kiziltan. "Phenytoin-Induced Parkinsonism." Singapore Med J 47, no. 11 (2006): 981-3.

Espay, A. J. "Reversible Parkinsonism and Ataxia Associated with High-Dose Octreotide." Neurology 70, no. 24 (2008): 2345-6.

Faught, E., R. Ayala, G. G. Montouris, I. E. Leppik, and Group Zonisamide 922 Trial. "Randomized Controlled Trial of Zonisamide for the Treatment of Refractory Partial-Onset Seizures." Neurology 57, no. 10 (2001): 1774-9.

Faught, E., B. J. Wilder, R. E. Ramsay, R. A. Reife, L. D. Kramer, G. W. Pledger, and R. M. Karim. "Topiramate Placebo-Controlled Dose-Ranging Trial in Refractory Partial Epilepsy Using 200-, 400-, and 600-Mg Daily Dosages. Topiramate Yd Study Group." Neurology 46, no. 6 (1996): 1684-90.

Ferbert, A., and A. Czernik. "[Persistent Cerebellar Syndrome Following Lithium Poisoning]." Nervenarzt 58, no. 12 (1987): 764-70.

Fisher, R. S., R. C. Sachdeo, J. Pellock, P. E. Penovich, L. Magnus, and P. Bernstein. "Rapid Initiation of Gabapentin: A Randomized, Controlled Trial." Neurology 56, no. 6 (2001): 743-8.

Fisk, G. G., and S. M. York. "The Effect of Sodium Valproate on Tardive Dyskinesia--Revisited." Br J Psychiatry 150, (1987): 542-6.

Fogoros, R. N., K. P. Anderson, R. A. Winkle, C. D. Swerdlow, and J. W. Mason. "Amiodarone: Clinical Efficacy and Toxicity in 96 Patients with Recurrent, Drug-Refractory Arrhythmias." Circulation 68, no. 1 (1983): 88-94.

French, J. A., B. W. Abou-Khalil, R. F. Leroy, E. M. Yacubian, P. Shin, S. Hall, H. Mansbach, V. Nohria, and Restore Study 301 Investigators. "Randomized, Double-Blind, Placebo-Controlled Trial of Ezogabine (Retigabine) in Partial Epilepsy." Neurology 76, no. 18 (2011): 1555-63.

French, J. A., A. R. Kugler, J. L. Robbins, L. E. Knapp, and E. A. Garofalo. "Dose-Response Trial of Pregabalin Adjunctive Therapy in Patients with Partial Seizures." Neurology 60, no. 10 (2003): 1631-7.

Friedman, J. H., and N. Shetty. "Permanent Cerebellar Toxicity of Cytosine Arabinoside (Ara C) in a Young Woman." Mov Disord 16, no. 3 (2001): 575-7.

Gannaway, D. J., and G. E. Mawer. "Serum Phenytoin Concentration and Clinical Response in Patients with Epilepsy." Br J Clin Pharmacol 12, no. 6 (1981): 833-9.

Garretto, N. S., R. D. Rey, G. Kohler, S. Cocorullo, D. A. Monteverde, B. I. Ravera, and R. E. Sica. "[Cerebellar Syndrome Caused by Amiodarone]." Arq Neuropsiquiatr 52, no. 4 (1994): 575-7.

Garson, A., Jr., J. D. Kugler, P. C. Gillette, A. Simonelli, and D. G. McNamara. "Control of Late Postoperative Ventricular Arrhythmias with Phenytoin in Young Patients." Am J Cardiol 46, no. 2 (1980): 290-4.

Gil-Nagel, A., J. Lopes-Lima, L. Almeida, J. Maia, P. Soares-da-Silva, and B. I. A. Investigators Study Group. "Efficacy and Safety of 800 and 1200 Mg Eslicarbazepine Acetate as Adjunctive

Treatment in Adults with Refractory Partial-Onset Seizures." Acta Neurol Scand 120, no. 5 (2009): 281-7.

Glasier, C. M., J. E. Stark, R. Brown, C. A. James, and J. W. Allison. "Rectal Thiopental Sodium for Sedation of Pediatric Patients Undergoing Mr and Other Imaging Studies." AJNR Am J Neuroradiol 16, no. 1 (1995): 111-4.

Gomceli, Y. B., G. Kutlu, L. Cavdar, F. Sanivar, and L. E. Inan. "Different Clinical Manifestations of Hyperammonemic Encephalopathy." Epilepsy Behav 10, no. 4 (2007): 583-7.

Gore, J. M., C. I. Haffajee, and J. S. Alpert. "Interaction of Amiodarone and Diphenylhydantoin." Am J Cardiol 54, no. 8 (1984): 1145.

Gottlieb, D., K. Bradstock, J. Koutts, T. Robertson, C. Lee, and P. Castaldi. "The Neurotoxicity of High-Dose Cytosine Arabinoside Is Age-Related." Cancer 60, no. 7 (1987): 1439-41.

Gottlieb, J. A., and J. K. Luce. "Cerebellar Ataxia with Weekly 5-Fluorouracil Administration." Lancet 1, no. 7690 (1971): 138-9.

Gram, L., P. Klosterskov, and M. Dam. "Gamma-Vinyl Gaba: A Double-Blind Placebo-Controlled Trial in Partial Epilepsy." Ann Neurol 17, no. 3 (1985): 262-6.

Graves, T. D., M. Condon, M. Loucaidou, and R. J. Perry. "Reversible Metronidazole-Induced Cerebellar Toxicity in a Multiple Transplant Recipient." J Neurol Sci 285, no. 1-2 (2009): 238-40.

Green, J. B. "Permanent Neurological Deficits Resulting from Lithium Toxicity." Ann Neurol 15, no. 1 (1984): 111.

Greene, H. L., E. L. Graham, J. A. Werner, G. K. Sears, B. W. Gross, J. P. Gorham, P. J. Kudenchuk, and G. B. Trobaugh. "Toxic and Therapeutic Effects of Amiodarone in the Treatment of Cardiac Arrhythmias." J Am Coll Cardiol 2, no. 6 (1983): 1114-28.

Grossman, L., M. A. Baker, D. M. Sutton, and J. H. Deck. "Central Nervous System Toxicity of High-Dose Cytosine Arabinoside." Med Pediatr Oncol 11, no. 4 (1983): 246-50.

Guerreiro, M. M., U. Vigonius, H. Pohlmann, M. L. de Manreza, N. Fejerman, S. A. Antoniuk, and A. Moore. "A Double-Blind Controlled Clinical Trial of Oxcarbazepine Versus Phenytoin in Children and Adolescents with Epilepsy." Epilepsy Res 27, no. 3 (1997): 205-13.

Gupta, V., T. P. Yadav, and A. Yadav. "Phenytoin Toxicity Presenting as Acute Meningo-Encephalitis in Children." Neurol India 59, no. 1 (2011): 66-7.

Hahn, K., G. Arendt, J. S. Braun, H. J. von Giesen, I. W. Husstedt, M. Maschke, M. E. Straube, E. Schielke, and Aids Working Group German Neuro. "A Placebo-Controlled Trial of Gabapentin for Painful Hiv-Associated Sensory Neuropathies." J Neurol 251, no. 10 (2004): 1260-6.

Halasz, P., R. Kalviainen, M. Mazurkiewicz-Beldzinska, F. Rosenow, P. Doty, D. Hebert, T. Sullivan, and S. P. Study Group. "Adjunctive Lacosamide for Partial-Onset Seizures: Efficacy and Safety Results from a Randomized Controlled Trial." Epilepsia 50, no. 3 (2009): 443-53.

Hamberg, P., F. A. De Jong, D. Brandsma, J. Verweij, and S. Sleijfer. "Irinotecan-Induced Central Nervous System Toxicity. Report on Two Cases and Review of the Literature." Acta Oncol 47, no. 5 (2008): 974-8.

Hamberg, P., R. C. Donders, and D. ten Bokkel Huinink. "Central Nervous System Toxicity Induced by Irinotecan." J Natl Cancer Inst 98, no. 3 (2006): 219.

Hamer, H. M., S. Knake, U. Schomburg, and F. Rosenow. "Valproate-Induced Hyperammonemic Encephalopathy in the Presence of Topiramate." Neurology 54, no. 1 (2000): 230-2.

Hansen, R., E. Quebbeman, P. Ritch, C. Chitambar, and T. Anderson. "Continuous 5-Fluorouracil (5fu) Infusion in Carcinoma of the Pancreas: A Phase Ii Study." Am J Med Sci 295, no. 2 (1988): 91-3.

Hari, A., B. A. Srikanth, and G. S. Lakshmi. "Metronidazole Induced Cerebellar Ataxia." Indian J Pharmacol 45, no. 3 (2013): 295-7.

Hasle, H. "Cerebellar Toxicity During Cytarabine Therapy Associated with Renal Insufficiency." Cancer Chemother Pharmacol 27, no. 1 (1990): 76-8.

Heaney, C. J., N. G. Campeau, and E. P. Lindell. "Mr Imaging and Diffusion-Weighted Imaging Changes in Metronidazole (Flagyl)-Induced Cerebellar Toxicity." AJNR Am J Neuroradiol 24, no. 8 (2003): 1615-7.

Hellden, A., U. Bergman, K. Engstrom Hellgren, M. Masquelier, I. Nilsson Remahl, I. Odar-Cederlof, M. Ramsjo, and L. Bertilsson. "Fluconazole-Induced Intoxication with Phenytoin in a Patient with Ultra-High Activity of Cyp2c9." Eur J Clin Pharmacol 66, no. 8 (2010): 791-5.

Herold, T. J. "Lamotrigine as a Possible Cause of Qrs Prolongation in a Patient with Known Seizure Disorder." CJEM 8, no. 5 (2006): 361-4.

Herzig, R. H., J. D. Hines, G. P. Herzig, S. N. Wolff, P. A. Cassileth, H. M. Lazarus, D. J. Adelstein, R. A. Brown, P. F. Coccia, S. Strandjord, and et al. "Cerebellar Toxicity with High-Dose Cytosine Arabinoside." J Clin Oncol 5, no. 6 (1987): 927-32.

Hindle, J. V., A. Ibrahim, and R. Ramaraj. "Ataxia Caused by Amiodarone in Older People." Age Ageing 37, no. 3 (2008): 347-8.

Hofstra, L. S., W. T. van der Graaf, E. G. de Vries, H. Haaxma-Reiche, and P. H. Willemse. "Ataxia Following Docetaxel Infusion." Ann Oncol 8, no. 8 (1997): 812-3.

Hommet, C., K. Mondon, B. de Toffol, and T. Constans. "Reversible Cognitive and Neurological Symptoms During Valproic Acid Therapy." J Am Geriatr Soc 55, no. 4 (2007): 628.

Huan, S., R. Pazdur, A. Singhakowinta, B. Samal, and V. K. Vaitkevicius. "Low-Dose Continuous Infusion 5-Fluorouracil. Evaluation in Advanced Breast Carcinoma." Cancer 63, no. 3 (1989): 419-22.

Huber, B., and M. Tomka-Hoffmeister. "Limited Efficacy of Gabapentin in Severe Therapy-Resistant Epilepsies of Learning-Disabled Patients." Seizure 12, no. 8 (2003): 602-3.

Ilagan, M. C., D. Carlson, and J. F. Madden. "Lithium Toxicity: Two Case Reports." Del Med J 74, no. 6 (2002): 263-70.

Imamura, T., A. Ejima, M. Sahara, H. Saito, and K. Tsuburaya. "[Cerebellar Atrophy and Persistent Cerebellar Ataxia after Acute Intoxication of Phenytoin]." No To Shinkei 44, no. 2 (1992): 149-53.

Iqbal, A., K. Tripathi, M. Rai, and A. N. Dwivedi. "Clinical and Imaging Perspective and Unanswered Questions in a Case of Metronidazole Induced Encephalopathy." Ann Indian Acad Neurol 16, no. 4 (2013): 569-71.

Irving, G., M. Jensen, M. Cramer, J. Wu, Y. K. Chiang, M. Tark, and M. Wallace. "Efficacy and Tolerability of Gastric-Retentive Gabapentin for the Treatment of Postherpetic Neuralgia: Results of a Double-Blind, Randomized, Placebo-Controlled Clinical Trial." Clin J Pain 25, no. 3 (2009): 185-92.

Jan, J. E., J. A. Riegl, J. U. Crichton, and H. G. Dunn. "Nitrazepam in the Treatmet of Epilepsy in Childhood." Can Med Assoc J 104, no. 7 (1971): 571-5.

Jawad, S., A. Richens, G. Goodwin, and W. C. Yuen. "Controlled Trial of Lamotrigine (Lamictal) for Refractory Partial Seizures." Epilepsia 30, no. 3 (1989): 356-63.

Johnson, G. F. "Lithium Neurotoxicity." Aust N Z J Psychiatry 10, no. 1 (1976): 33-8.

Kafadar, I., F. Moustafa, K. Yalcn, and B. A. Klc. "A Rare Adverse Effect of Metronidazole: Nervous System Symptoms." Pediatr Emerg Care 29, no. 6 (2013): 751-2.

Kaleyias, J., E. Faerber, and S. V. Kothare. "Tacrolimus Induced Subacute Cerebellar Ataxia." Eur J Paediatr Neurol 10, no. 2 (2006): 86-9.

Kalra, V., R. Seth, D. Mishra, and N. C. Saha. "Clobazam in Refractory Childhood Epilepsy." Indian J Pediatr 77, no. 3 (2010): 263-6.

Kerry, R. J., C. M. McDermott, and J. E. Orme. "Bromazepam, Medazepam, Chlordiazepoxide in Treatment of Neurotic Anxiety." Br J Psychiatry 124, no. 0 (1974): 485-6.

Kifune, A., F. Kubota, N. Shibata, T. Akata, and S. Kikuchi. "Valproic Acid-Induced Hyperammonemic Encephalopathy with Triphasic Waves." Epilepsia 41, no. 7 (2000): 909-12.

Kimos, P., C. Biggs, J. Mah, G. Heo, S. Rashiq, N. M. Thie, and P. W. Major. "Analgesic Action of Gabapentin on Chronic Pain in the Masticatory Muscles: A Randomized Controlled Trial." Pain 127, no. 1-2 (2007): 151-60.

Kores, B., and M. H. Lader. "Irreversible Lithium Neurotoxicity: An Overview." Clin Neuropharmacol 20, no. 4 (1997): 283-99.

Kothare, S. V., D. S. Khurana, N. Mostofi, J. J. Melvin, H. G. Marks, I. Valencia, and A. Legido. "Oxcarbazepine Monotherapy in Children and Adolescents: A Single-Center Clinical Experience." Pediatr Neurol 35, no. 4 (2006): 235-9.

Krauser, D. G., A. Z. Segal, and P. Kligfield. "Severe Ataxia Caused by Amiodarone." Am J Cardiol 96, no. 10 (2005): 1463-4.

Kuruvilla, T., and N. E. Bharucha. "Cerebellar Atrophy after Acute Phenytoin Intoxication." Epilepsia 38, no. 4 (1997): 500-2.

Lam, M. S., D. A. Kaufman, and M. P. Russin. "Capecitabine-Associated Cerebellar Ataxia." Am J Health Syst Pharm 65, no. 21 (2008): 2032-5.

Lang, E. J., and S. M. Davis. "Lithium Neurotoxicity: The Development of Irreversible Neurological Impairment Despite Standard Monitoring of Serum Lithium Levels." J Clin Neurosci 9, no. 3 (2002): 308-9.

Langan, Y. M., R. Lucas, H. Jewell, N. Toublanc, H. Schaefer, J. W. Sander, and P. N. Patsalos. "Talampanel, a New Antiepileptic Drug: Single- and Multiple-Dose Pharmacokinetics and Initial 1-Week Experience in Patients with Chronic Intractable Epilepsy." Epilepsia 44, no. 1 (2003): 46-53.

Lazarus, H. M., R. H. Herzig, G. P. Herzig, G. L. Phillips, U. Roessmann, and D. J. Fishman. "Central Nervous System Toxicity of High-Dose Systemic Cytosine Arabinoside." Cancer 48, no. 12 (1981): 2577-82.

Leppik, I. E., L. J. Willmore, R. W. Homan, G. Fromm, K. J. Oommen, J. K. Penry, J. C. Sackellares, D. B. Smith, R. P. Lesser, J. D. Wallace, and et al. "Efficacy and Safety of Zonisamide: Results of a Multicenter Study." Epilepsy Res 14, no. 2 (1993): 165-73.

Lesser, H., U. Sharma, L. LaMoreaux, and R. M. Poole. "Pregabalin Relieves Symptoms of Painful Diabetic Neuropathy: A Randomized Controlled Trial." Neurology 63, no. 11 (2004): 2104-10.

Lewis, D. A. "Unrecognized Chronic Lithium Neurotoxic Reactions." JAMA 250, no. 15 (1983): 2029-30.

Lindvall, O., and B. Nilsson. "Cerebellar Atrophy Following Phenytoin Intoxication." Ann Neurol 16, no. 2 (1984): 258-60.

Livingston, J. H., D. Beaumont, A. Arzimanoglou, and J. Aicardi. "Vigabatrin in the Treatment of Epilepsy in Children." Br J Clin Pharmacol 27 Suppl 1, (1989): 109S-112S.

Loiseau, P., A. W. Yuen, B. Duche, T. Menager, and M. C. Arne-Bes. "A Randomised Double-Blind Placebo-Controlled Crossover Add-on Trial of Lamotrigine in Patients with Treatment-Resistant Partial Seizures." Epilepsy Res 7, no. 2 (1990): 136-45.

"The Long-Term Safety and Efficacy of Gabapentin (Neurontin) as Add-on Therapy in Drug-Resistant Partial Epilepsy. The Us Gabapentin Study Group." Epilepsy Res 18, no. 1 (1994): 67-73.

Lopez-Ariztegui, N., M. Ochoa, M. J. Sanchez-Migallon, C. Nevado, and M. Martin. "[Acute Phenytoin Poisoning Secondary to an Interaction with Ticlopidine]." Rev Neurol 26, no. 154 (1998): 1017-8.

Maltby, J. R., R. C. Hamilton, and R. Phillips. "Comparison of Flunitrazepam and Thiopentone for Induction of General Anaesthesia." Can Anaesth Soc J 27, no. 4 (1980): 331-7.

Mamiya, K., K. Kojima, E. Yukawa, S. Higuchi, I. Ieiri, H. Ninomiya, and N. Tashiro. "Phenytoin Intoxication Induced by Fluvoxamine." Ther Drug Monit 23, no. 1 (2001): 75-7.

Mancuso, C. E., M. G. Tanzi, and M. Gabay. "Paradoxical Reactions to Benzodiazepines: Literature Review and Treatment Options." Pharmacotherapy 24, no. 9 (2004): 1177-85.

Manto, M., E. Godaux, J. Jacquy, and J. G. Hildebrand. "Analysis of Cerebellar Dysmetria Associated with Lithium Intoxication." Neurol Res 18, no. 5 (1996): 416-24.

Marson, A. G., A. M. Al-Kharusi, M. Alwaidh, R. Appleton, G. A. Baker, D. W. Chadwick, C. Cramp, O. C. Cockerell, P. N. Cooper, J. Doughty, B. Eaton, C. Gamble, P. J. Goulding, S. J. Howell, A. Hughes, M. Jackson, A. Jacoby, M. Kellett, G. R. Lawson, J. P. Leach, P. Nicolaides, R. Roberts, P. Shackley, J. Shen, D. F. Smith, P. E. Smith, C. T. Smith, A. Vanoli, P. R. Williamson, and Sanad Study group. "The Sanad Study of Effectiveness of Carbamazepine, Gabapentin, Lamotrigine, Oxcarbazepine, or Topiramate for Treatment of Partial Epilepsy: An Unblinded Randomised Controlled Trial." Lancet 369, no. 9566 (2007): 1000-15.

________. "The Sanad Study of Effectiveness of Valproate, Lamotrigine, or Topiramate for Generalised and Unclassifiable Epilepsy: An Unblinded Randomised Controlled Trial." Lancet 369, no. 9566 (2007): 1016-26.

Matilainen, R., A. Pitkanen, T. Ruutiainen, E. Mervaala, and P. Riekkinen. "Vigabatrin in Epilepsy in Mentally Retarded Patients." Br J Clin Pharmacol 27 Suppl 1, (1989): 113S-118S.

Matsuo, F., D. Bergen, E. Faught, J. A. Messenheimer, A. T. Dren, G. D. Rudd, and C. G. Lineberry. "Placebo-Controlled Study of the Efficacy and Safety of Lamotrigine in Patients with Partial Seizures. U.S. Lamotrigine Protocol 0.5 Clinical Trial Group." Neurology 43, no. 11 (1993): 2284-91.

McGovern, B., H. Garan, E. Kelly, and J. N. Ruskin. "Adverse Reactions During Treatment with Amiodarone Hydrochloride." Br Med J (Clin Res Ed) 287, no. 6386 (1983): 175-80.

Mehndiratta, M. M., M. Krishnamurthy, K. N. Rajesh, and G. Singh. "Clobazam Monotherapy in Drug Naive Adult Patients with Epilepsy." Seizure 12, no. 4 (2003): 226-8.

Messenheimer, J. A., L. Giorgi, and M. E. Risner. "The Tolerability of Lamotrigine in Children." Drug Saf 22, no. 4 (2000): 303-12.

Messenheimer, J., R. E. Ramsay, L. J. Willmore, R. F. Leroy, J. J. Zielinski, R. Mattson, J. M. Pellock, A. M. Valakas, G. Womble, and M. Risner. "Lamotrigine Therapy for Partial Seizures: A Multicenter, Placebo-Controlled, Double-Blind, Cross-over Trial." Epilepsia 35, no. 1 (1994): 113-21.

Miller, C. G., and R. Carpenter. "Neurotoxic Side-Effects of Piperazine." Lancet 1, no. 7495 (1967): 895-6.

Miller, L. G., and C. B. Panosian. "Ataxia and Slurred Speech after Artesunate Treatment for Falciparum Malaria." N Engl J Med 336, no. 18 (1997): 1328.

Moertel, C. G., R. J. Reitemeier, C. F. Bolton, and R. G. Shorter. "Cerebellar Ataxia Associated with Fluorinated Pyrimidine Therapy." Cancer Chemother Rep 41, (1964): 15-8.

Moosa, A. N., and D. Perkins. "Neurological Picture. Mri of Metronidazole Induced Cerebellar Ataxia." J Neurol Neurosurg Psychiatry 81, no. 7 (2010): 754-5.

Morady, F., M. J. Sauve, P. Malone, E. N. Shen, A. B. Schwartz, A. Bhandari, E. Keung, R. J. Sung, and M. M. Scheinman. "Long-Term Efficacy and Toxicity of High-Dose Amiodarone Therapy for Ventricular Tachycardia or Ventricular Fibrillation." Am J Cardiol 52, no. 8 (1983): 975-9.

Morady, F., M. M. Scheinman, and D. S. Hess. "Amiodarone in the Management of Patients with Ventricular Tachycardia and Ventricular Fibrillation." Pacing Clin Electrophysiol 6, no. 3 Pt 1 (1983): 609-15.

Morello, C. M., S. G. Leckband, C. P. Stoner, D. F. Moorhouse, and G. A. Sahagian. "Randomized Double-Blind Study Comparing the Efficacy of Gabapentin with Amitriptyline on Diabetic Peripheral Neuropathy Pain." Arch Intern Med 159, no. 16 (1999): 1931-7.

Morris, G. L., 3rd. "Efficacy and Tolerability of Gabapentin in Clinical Practice." Clin Ther 17, no. 5 (1995): 891-900.

Mukesh, M., and P. Murray. "Cerebellar Toxicity with Capecitabine in a Patient with Metastatic Breast Cancer." Clin Oncol (R Coll Radiol) 20, no. 5 (2008): 382-3.

Murphy, A., and K. Wilbur. "Phenytoin-Diazepam Interaction." Ann Pharmacother 37, no. 5 (2003): 659-63.

Murphy, J. M., R. Motiwala, and O. Devinsky. "Phenytoin Intoxication." South Med J 84, no. 10 (1991): 1199-204.

Nagaraja, D., A. B. Taly, R. N. Sahu, S. M. Channabasavanna, and H. S. Narayanan. "Permanent Neurological Sequelae Due to Lithium Toxicity." Clin Neurol Neurosurg 89, no. 1 (1987): 31-4.

Nand, S., H. L. Messmore, Jr., R. Patel, S. G. Fisher, and R. I. Fisher. "Neurotoxicity Associated with Systemic High-Dose Cytosine Arabinoside." J Clin Oncol 4, no. 4 (1986): 571-5.

Negevesky, G. J., M. P. Kolsky, R. Laureno, and T. H. Yau. "Reversible Atorvastatin-Associated External Ophthalmoplegia, Anti-Acetylcholine Receptor Antibodies, and Ataxia." Arch Ophthalmol 118, no. 3 (2000): 427-8.

Nielsen, K. A., M. Dahl, E. Tommerup, and P. Wolf. "Comparative Daily Profiles with Different Preparations of Lamotrigine: A Pilot Investigation." Epilepsy Behav 13, no. 1 (2008): 127-30.

Niethammer, M., and B. Ford. "Permanent Lithium-Induced Cerebellar Toxicity: Three Cases and Review of Literature." Mov Disord 22, no. 4 (2007): 570-3.

Nussbaum, E. S., R. E. Maxwell, P. B. Bitterman, M. I. Hertz, W. Bula, and R. E. Latchaw. "Cyclosporine a Toxicity Presenting with Acute Cerebellar Edema and Brainstem Compression. Case Report." J Neurosurg 82, no. 6 (1995): 1068-70.

Odeh, M., H. Seligmann, and A. Oliven. "Propafenone-Induced Ataxia: Report of Three Cases." Am J Med Sci 320, no. 2 (2000): 151-3.

Ohara, S., R. Hayashi, H. Momoi, J. Miki, and N. Yanagisawa. "Mexiletine in the Treatment of Spasmodic Torticollis." Mov Disord 13, no. 6 (1998): 934-40.

Onofrj, M., and A. Thomas. "Acetazolamide-Responsive Periodic Ataxia Induced by Amiodarone." Mov Disord 14, no. 2 (1999): 379-81.

Orr, C. F., and J. E. Ahlskog. "Frequency, Characteristics, and Risk Factors for Amiodarone Neurotoxicity." Arch Neurol 66, no. 7 (2009): 865-9.

Osuna, M. T., J. Burcet, L. Ramio, X. Ustrell, Y. Silva, and A. Molins. "[Hyperammonemic Encephalopathy Associated with Valproate Acid]." Neurologia 18, no. 6 (2003): 347-50.

Ozsoy, S., M. Basturk, and E. Esel. "Cerebellar Syndrome in a Patient with Pneumonia under Lithium Treatment: A Case Report." Prog Neuropsychopharmacol Biol Psychiatry 30, no. 8 (2006): 1532-4.

Palakurthy, P. R., V. Iyer, and R. J. Meckler. "Unusual Neurotoxicity Associated with Amiodarone Therapy." Arch Intern Med 147, no. 5 (1987): 881-4.

Panda, S., and K. Radhakrishnan. "Two Cases of Valproate-Induced Hyperammonemic Encephalopathy without Hepatic Failure." J Assoc Physicians India 52, (2004): 746-8.

Pande, A. C., J. G. Crockatt, D. E. Feltner, C. A. Janney, W. T. Smith, R. Weisler, P. D. Londborg, R. J. Bielski, D. L. Zimbroff, J. R. Davidson, and M. Liu-Dumaw. "Pregabalin in Generalized Anxiety Disorder: A Placebo-Controlled Trial." Am J Psychiatry 160, no. 3 (2003): 533-40.

Pande, A. C., D. E. Feltner, J. W. Jefferson, J. R. Davidson, M. Pollack, M. B. Stein, R. B. Lydiard, R. Futterer, P. Robinson, M. Slomkowski, E. DuBoff, M. Phelps, C. A. Janney, and J. L. Werth. "Efficacy of the Novel Anxiolytic Pregabalin in Social Anxiety Disorder: A Placebo-Controlled, Multicenter Study." J Clin Psychopharmacol 24, no. 2 (2004): 141-9.

Park, K. I., J. M. Chung, and J. Y. Kim. "Metronidazole Neurotoxicity: Sequential Neuroaxis Involvement." Neurol India 59, no. 1 (2011): 104-7.

Parsons, A. C. "Piperazine Neurotoxicity: "Worm Wobble"." Br Med J 4, no. 5790 (1971): 792.

Patel, K., I. Green-Hopkins, S. Lu, and A. R. Tunkel. "Cerebellar Ataxia Following Prolonged Use of Metronidazole: Case Report and Literature Review." Int J Infect Dis 12, no. 6 (2008): e111-4.

Patsalos, P. N., T. J. Stephenson, S. Krishna, A. A. Elyas, P. T. Lascelles, and C. M. Wiles. "Side-Effects Induced by Carbamazepine-10,11-Epoxide." Lancet 2, no. 8469-70 (1985): 1432.

Pazdur, R., J. A. Ajani, R. Winn, J. Bearden, R. J. Belt, S. Pilat, R. Hallinan, and B. Levin. "A Phase Ii Trial of 5-Fluorouracil and Recombinant Alpha-2a-Interferon in Previously Untreated Metastatic Gastric Carcinoma." Cancer 69, no. 4 (1992): 878-82.

Perney, P., F. Blanc, G. Mourad, J. P. Blayac, and D. Hillaire-Buys. "Transitory Ataxia Related to Topically Administered Lidocaine." Ann Pharmacother 38, no. 5 (2004): 828-30.

Perry, J. R., and E. Warner. "Transient Encephalopathy after Paclitaxel (Taxol) Infusion." Neurology 46, no. 6 (1996): 1596-9.

Perugi, G., C. Toni, F. Frare, G. Ruffolo, L. Moretti, C. Torti, and H. S. Akiskal. "Effectiveness of Adjunctive Gabapentin in Resistant Bipolar Disorder: Is It Due to Anxious-Alcohol Abuse Comorbidity?" J Clin Psychopharmacol 22, no. 6 (2002): 584-91.

Pirzada, N. A., Ali, II, and R. M. Dafer. "Fluorouracil-Induced Neurotoxicity." Ann Pharmacother 34, no. 1 (2000): 35-8.

Ponseti, J. M., J. Azem, J. M. Fort, M. Lopez-Cano, R. Vilallonga, M. Buera, C. Cervera, and M. Armengol. "Long-Term Results of Tacrolimus in Cyclosporine- and Prednisone-Dependent Myasthenia Gravis." Neurology 64, no. 9 (2005): 1641-3.

Porges, Y., S. Blumen, Z. Fireman, A. Sternberg, and D. Zamir. "Cyclosporine-Induced Optic Neuropathy, Ophthalmoplegia, and Nystagmus in a Patient with Crohn Disease." Am J Ophthalmol 126, no. 4 (1998): 607-9.

Prettyman, R. "Lithium Neurotoxicity at Subtherapeutic Serum Levels." Br J Psychiatry 164, no. 1 (1994): 123.

Prevoznik, S. J. "Truncal Ataxia as a Complication of Colistin Therapy: Its Relation to Spinal Anesthesia." Anesth Analg 46, no. 1 (1967): 46-8.

Privitera, M., R. Fincham, J. Penry, R. Reife, L. Kramer, G. Pledger, and R. Karim. "Topiramate Placebo-Controlled Dose-Ranging Trial in Refractory Partial Epilepsy Using 600-, 800-, and 1,000-Mg Daily Dosages. Topiramate Ye Study Group." Neurology 46, no. 6 (1996): 1678-83.

Raadal, M., S. E. Coldwell, T. Kaakko, P. Milgrom, P. Weinstein, V. Perkis, and H. W. Karl. "A Randomized Clinical Trial of Triazolam in 3- to 5-Year-Olds." J Dent Res 78, no. 6 (1999): 1197-203.

Rao, R. D., P. J. Flynn, J. A. Sloan, G. Y. Wong, P. Novotny, D. B. Johnson, H. M. Gross, S. I. Renno, M. Nashawaty, and C. L. Loprinzi. "Efficacy of Lamotrigine in the Management of Chemotherapy-Induced Peripheral Neuropathy: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Trial, N01c3." Cancer 112, no. 12 (2008): 2802-8.

Reife, R., G. Pledger, and S. C. Wu. "Topiramate as Add-on Therapy: Pooled Analysis of Randomized Controlled Trials in Adults." Epilepsia 41 Suppl 1, (2000): S66-71.

Renouf, D., and S. Gill. "Capecitabine-Induced Cerebellar Toxicity." Clin Colorectal Cancer 6, no. 1 (2006): 70-1.

Richens, A., and S. Ahmad. "Controlled Trial of Sodium Valproate in Severe Epilepsy." Br Med J 4, no. 5991 (1975): 255-6.

Ringelstein, A., K. Bongs, B. Sorge-Hadicke, and P. Berlit. "[Case of Inflammatory Vasculopathy and Encephalopathy Caused by Treatment with Tacrolimus]." Nervenarzt 76, no. 4 (2005): 475-8.

Robertson, K., C. B. von Stempel, and I. Arnold. "When Less Is More: A Case of Phenytoin Toxicity." BMJ Case Rep 2013, (2013).

Rose, W., C. Kirubakaran, and J. X. Scott. "Intermittent Clobazam Therapy in Febrile Seizures." Indian J Pediatr 72, no. 1 (2005): 31-3.

Rosenfeld, W. E., R. C. Sachdeo, R. E. Faught, and M. Privitera. "Long-Term Experience with Topiramate as Adjunctive Therapy and as Monotherapy in Patients with Partial Onset

Seizures: Retrospective Survey of Open-Label Treatment." Epilepsia 38 Suppl 1, (1997): S34-6.

Rottach, K. G., J. Weiss-Brummer, U. Wieland, and M. Schmauss. "[Valproic Acid in Prophylaxis of Bipolar Disorder. A Case of Valproate-Induced Encephalopathy]." Nervenarzt 71, no. 5 (2000): 401-3.

Rowbotham, M., N. Harden, B. Stacey, P. Bernstein, and L. Magnus-Miller. "Gabapentin for the Treatment of Postherpetic Neuralgia: A Randomized Controlled Trial." JAMA 280, no. 21 (1998): 1837-42.

Sacchi, S., H. M. Kantarjian, E. J. Freireich, S. O'Brien, J. Cortes, M. B. Rios, S. Kornblau, F. J. Giles, C. Koller, J. Gajewski, and M. Talpaz. "Unexpected High Incidence of Severe Toxicities Associated with Alpha Interferon, Low-Dose Cytosine Arabinoside and All-Trans Retinoic Acid in Patients with Chronic Myelogenous Leukemia." Leuk Lymphoma 35, no. 5-6 (1999): 483-9.

Sachdeo, R., A. Beydoun, S. Schachter, B. Vazquez, N. Schaul, P. Mesenbrink, L. Kramer, and J. D'Souza. "Oxcarbazepine (Trileptal) as Monotherapy in Patients with Partial Seizures." Neurology 57, no. 5 (2001): 864-71.

Sackellares, J. C., R. E. Ramsay, B. J. Wilder, T. R. Browne, 3rd, and M. K. Shellenberger. "Randomized, Controlled Clinical Trial of Zonisamide as Adjunctive Treatment for Refractory Partial Seizures." Epilepsia 45, no. 6 (2004): 610-7.

Salinsky, M. C., R. L. Levine, J. P. Aubuchon, and H. S. Schutta. "Acute Cerebellar Dysfunction with High-Dose Ara-C Therapy." Cancer 51, no. 3 (1983): 426-9.

Saltz, L., N. Kemeny, G. Schwartz, and D. Kelsen. "A Phase Ii Trial of Alpha-Interferon and 5-Fluorouracil in Patients with Advanced Carcinoid and Islet Cell Tumors." Cancer 74, no. 3 (1994): 958-61.

Sanchez-Romero, A., J. A. Duran-Quintana, R. Garcia-Delgado, C. Margarito-Rangel, and J. L. Poveda-Andres. "[Possible Gabapentin Phenytoin Interaction]." Rev Neurol 34, no. 10 (2002): 952-3.

Sander, J. W., P. N. Patsalos, J. R. Oxley, M. J. Hamilton, and W. C. Yuen. "A Randomised Double-Blind Placebo-Controlled Add-on Trial of Lamotrigine in Patients with Severe Epilepsy." Epilepsy Res 6, no. 3 (1990): 221-6.

Sander, J. W., P. C. Trevisol-Bittencourt, Y. M. Hart, P. N. Patsalos, and S. D. Shorvon. "The Efficacy and Long-Term Tolerability of Lamotrigine in the Treatment of Severe Epilepsy." Epilepsy Res 7, no. 3 (1990): 226-9.

Sarna, J. R., S. Furtado, and A. K. Brownell. "Neurologic Complications of Metronidazole." Can J Neurol Sci 40, no. 6 (2013): 768-76.

Schapel, G. J., R. G. Beran, F. J. Vajda, S. F. Berkovic, M. L. Mashford, F. M. Dunagan, W. C. Yuen, and G. Davies. "Double-Blind, Placebo Controlled, Crossover Study of Lamotrigine in Treatment Resistant Partial Seizures." J Neurol Neurosurg Psychiatry 56, no. 5 (1993): 448-53.

Schaub, J. E., P. J. Williamson, E. W. Barnes, and P. N. Trewby. "Multisystem Adverse Reaction to Lamotrigine." Lancet 344, no. 8920 (1994): 481.

Schlumberger, E., F. Chavez, L. Palacios, E. Rey, N. Pajot, and O. Dulac. "Lamotrigine in Treatment of 120 Children with Epilepsy." Epilepsia 35, no. 2 (1994): 359-67.

Schmidt, D., R. Jacob, P. Loiseau, E. Deisenhammer, D. Klinger, A. Despland, M. Egli, G. Bauer, E. Stenzel, and V. Blankenhorn. "Zonisamide for Add-on Treatment of Refractory Partial Epilepsy: A European Double-Blind Trial." Epilepsy Res 15, no. 1 (1993): 67-73.

Schneider, J. A., and S. S. Mirra. "Neuropathologic Correlates of Persistent Neurologic Deficit in Lithium Intoxication." Ann Neurol 36, no. 6 (1994): 928-31.

Schwartz, T. H., V. V. Karpitskiy, and R. S. Sohn. "Intravenous Valproate Sodium in the Treatment of Daily Headache." Headache 42, no. 6 (2002): 519-22.

Sellers, J., P. Tyrer, A. Whiteley, D. C. Banks, and D. H. Barer. "Neurotoxic Effects of Lithium with Delayed Rise in Serum Lithium Levels." Br J Psychiatry 140, (1982): 623-5.

Sethi, A. S., A. M. Jain, and V. Chawla. "Piperazine Toxicity. Report of a Case." Indian J Pediatr 35, no. 244 (1968): 237-8.

Sharief, M. K., J. W. Sander, and S. D. Shorvon. "Acute Encephalopathy with Vigabatrin." Lancet 342, no. 8871 (1993): 619.

Sharma, S., and S. K. Dasroy. "Images in Clinical Medicine. Gingival Hyperplasia Induced by Phenytoin." N Engl J Med 342, no. 5 (2000): 325.

Shenkman, Z., M. Findler, A. Lossos, S. Barak, and J. Katz. "Permanent Neurologic Deficit after Inferior Alveolar Nerve Block: A Case Report." Int J Oral Maxillofac Surg 25, no. 5 (1996): 381-2.

Shroff, R., and B. Houston. "Unusual Cerebellar Ataxia: "Worm Wobble" Revisited." Arch Dis Child 87, no. 4 (2002): 333-4.

Simonetta, F., F. Christou, R. E. Vandoni, and T. Nierle. "Walking Unsteadily: A Case of Acute Cerebellar Ataxia." BMJ Case Rep 2013, (2013).

Singh, S. V. "Lithium Carbonate/Fluphenazine Decanoate Producing Irreversible Brain Damage." Lancet 2, no. 8292 (1982): 278.

"Single-Blind, Placebo-Controlled Multicenter Trial of Vigabatrin in the Treatment of Epilepsy. The Italian Study Group on Vigabatrin." Ital J Neurol Sci 13, no. 9 (1992): 741-7.

Sirven, J. I., T. D. Fife, D. M. Wingerchuk, and J. F. Drazkowski. "Second-Generation Antiepileptic Drugs' Impact on Balance: A Meta-Analysis." Mayo Clin Proc 82, no. 1 (2007): 40-7.

Smith, D., G. Baker, G. Davies, M. Dewey, and D. W. Chadwick. "Outcomes of Add-on Treatment with Lamotrigine in Partial Epilepsy." Epilepsia 34, no. 2 (1993): 312-22.

Snavely, S. R., and G. R. Hodges. "The Neurotoxicity of Antibacterial Agents." Ann Intern Med 101, no. 1 (1984): 92-104.

Sokol, D. K., J. P. Molleston, R. S. Filo, J. Van Valer, and M. Edwards-Brown. "Tacrolimus (Fk506)-Induced Mutism after Liver Transplant." Pediatr Neurol 28, no. 2 (2003): 156-8.

Sorensen, P., L. J. Andersen, O. Hansen, and L. Bastholt. "Long-Term Continuous 5-Fluorouracil Infusion in Patients with Advanced Head and Neck Cancer." Acta Oncol 38, no. 8 (1999): 1043-5.

Spira, P. J., R. G. Beran, and Group Australian Gabapentin Chronic Daily Headache. "Gabapentin in the Prophylaxis of Chronic Daily Headache: A Randomized, Placebo-Controlled Study." Neurology 61, no. 12 (2003): 1753-9.

Steinhoff, B. J., G. Herrendorf, H. J. Bittermann, and C. Kurth. "Isolated Ataxia as an Idiosyncratic Side-Effect under Gabapentin." Seizure 6, no. 6 (1997): 503-4.

Strimel, W. J., A. Woodruff, P. Cheung, B. F. Kirmani, and S. K. Stephen Huang. "Brugada-Like Electrocardiographic Pattern Induced by Lamotrigine Toxicity." Clin Neuropharmacol 33, no. 5 (2010): 265-7.

Stuart, K., J. Tessitore, and M. Huberman. "5-Fluorouracil and Alpha-Interferon in Hepatocellular Carcinoma." Am J Clin Oncol 19, no. 2 (1996): 136-9.

Sung, S. F., P. C. Chiang, H. H. Tung, and C. T. Ong. "Charcoal Hemoperfusion in an Elderly Man with Life-Threatening Adverse Reactions Due to Poor Metabolism of Phenytoin." J Formos Med Assoc 103, no. 8 (2004): 648-52.

Sylvester, R. K., A. J. Fisher, and M. Lobell. "Cytarabine-Induced Cerebellar Syndrome: Case Report and Literature Review." Drug Intell Clin Pharm 21, no. 2 (1987): 177-80.

Takase, K., Y. Santa, S. Ohta, and T. Yoshimura. "[Mri and Spect Findings in a Case of Metronidazole-Induced Reversible Acute Cerebellar Ataxia]." Rinsho Shinkeigaku 45, no. 5 (2005): 386-9.

Tan, C. H., Y. F. Chen, C. C. Chen, C. C. Chao, H. H. Liou, and S. T. Hsieh. "Painful Neuropathy Due to Skin Denervation after Metronidazole-Induced Neurotoxicity." J Neurol Neurosurg Psychiatry 82, no. 4 (2011): 462-5.

Tartara, A., R. Manni, C. A. Galimberti, J. P. Mumford, A. Iudice, and E. Perucca. "Vigabatrin in the Treatment of Epilepsy: A Long-Term Follow-up Study." J Neurol Neurosurg Psychiatry 52, no. 4 (1989): 467-71.

Taskapilioglu, O., M. Seferoglu, E. Kaygili, B. Hakyemez, and M. Zarifoglu. "Reversible Cerebellar Toxicity During Treatment with Ornidazole: The First Case Report." J Neurol Neurosurg Psychiatry 81, no. 3 (2010): 349-50.

Tassinari, C. A., R. Michelucci, P. Chauvel, J. Chodkiewicz, S. Shorvon, O. Henriksen, M. Dam, R. Reife, G. Pledger, and R. Karim. "Double-Blind, Placebo-Controlled Trial of Topiramate (600 Mg Daily) for the Treatment of Refractory Partial Epilepsy." Epilepsia 37, no. 8 (1996): 763-8.

Teive, H. A., R. P. Munhoz, and L. C. Werneck. "Acquired Cerebellar Ataxia Due to Statin Use." Arq Neuropsiquiatr 70, no. 2 (2012): 152.

Teta, D., P. A. Uldry, and F. Regli. "[Reversible Ophthalmoplegia, Cerebellar Syndrome and Vigilance Disorders Following Phenytoin Poisoning]." Schweiz Med Wochenschr 120, no. 41 (1990): 1504-7.

Thome-Souza, S., A. Freitas, L. A. Fiore, and K. D. Valente. "Lamotrigine and Valproate: Efficacy of Co-Administration in a Pediatric Population." Pediatr Neurol 28, no. 5 (2003): 360-4.

Thome-Souza, S., B. Moreira, and K. D. Valente. "Late Adverse Effects of the Coadministration of Valproate and Lamotrigine." Pediatr Neurol 47, no. 1 (2012): 47-50.

Thompson, C. B., C. H. June, K. M. Sullivan, and E. D. Thomas. "Association between Cyclosporin Neurotoxicity and Hypomagnesaemia." Lancet 2, no. 8412 (1984): 1116-20.

Tweedy, C. M., P. Milgrom, E. D. Kharasch, T. Kaakko, M. Spieker, and S. E. Coldwell. "Pharmacokinetics and Clinical Effects of Sublingual Triazolam in Pediatric Dental Patients." J Clin Psychopharmacol 21, no. 3 (2001): 268-72.

Uchigata, M., H. Tanabe, I. Hasue, and M. Kurihara. "Peripheral Neuropathy Due to Lithium Intoxication." Ann Neurol 9, no. 4 (1981): 414.

van de Vusse, A. C., S. G. Stomp-van den Berg, A. H. Kessels, and W. E. Weber. "Randomised Controlled Trial of Gabapentin in Complex Regional Pain Syndrome Type 1 [Isrctn84121379]." BMC Neurol 4, (2004): 13.

van de Warrenburg, B. P., J. van Gaalen, S. Boesch, J. M. Burgunder, A. Durr, P. Giunti, T. Klockgether, C. Mariotti, M. Pandolfo, and O. Riess. "Efns/Ens Consensus on the Diagnosis and Management of Chronic Ataxias in Adulthood." Eur J Neurol 21, no. 4 (2014): 552-62.

van Gaalen, J., and B. P. van de Warrenburg. "A Practical Approach to Late-Onset Cerebellar Ataxia: Putting the Disorder with Lack of Order into Order." Pract Neurol 12, no. 1 (2012): 14-24.

Verdoux, H., and M. L. Bourgeois. "A Case of Lithium Neurotoxicity with Irreversible Cerebellar Syndrome." J Nerv Ment Dis 178, no. 12 (1990): 761-2.

Vogt, D. P., R. J. Lederman, W. D. Carey, and T. A. Broughan. "Neurologic Complications of Liver Transplantation." Transplantation 45, no. 6 (1988): 1057-61.

Von Hartitzsch, B., N. A. Hoenich, R. J. Leigh, R. Wilkinson, T. H. Frost, A. Weddel, and G. A. Posen. "Permanent Neurological Sequelae Despite Haemodialysis for Lithium Intoxication." Br Med J 4, no. 5843 (1972): 757-9.

Vossler, D. G., G. L. Morris, 3rd, C. L. Harden, G. Montouris, E. Faught, A. M. Kanner, A. Fix, J. A. French, and investigators Postmarketing Antiepileptic Drug Survey group study. "Tiagabine in Clinical Practice: Effects on Seizure Control and Behavior." Epilepsy Behav 28, no. 2 (2013): 211-6.

Vossler, D. G., A. J. Wilensky, D. F. Cawthon, D. L. Kraemer, L. M. Ojemann, L. M. Caylor, and J. D. Morgan. "Serum and Csf Glutamine Levels in Valproate-Related Hyperammonemic Encephalopathy." Epilepsia 43, no. 2 (2002): 154-9.

Vredeveld, C. J., and H. H. Morre. "[Lithium Neurotoxicity in Advanced Age. 2 Case Reports with a Literature Review]." Nervenarzt 54, no. 7 (1983): 377-80.

Watanabe, T. "Ataxia as a Delayed Reaction to Contrast Medium for an Intravenous Pyelography." Pediatr Nephrol 18, no. 3 (2003): 303.

Weisler, R. H., P. E. Keck, Jr., A. C. Swann, A. J. Cutler, T. A. Ketter, A. H. Kalali, and S. P. D. Study Group. "Extended-Release Carbamazepine Capsules as Monotherapy for Acute Mania in Bipolar Disorder: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial." J Clin Psychiatry 66, no. 3 (2005): 323-30.

Wessely, P., N. Mayr, H. Binder, and D. Klingler. "[Neurological Signs in Diphenylhydantoin Intoxication (Case Reports and Review) (Author's Transl)]." Wien Klin Wochenschr 93, no. 10 (1981): 315-21.

Willis, M. S., and A. M. Lugo. "Amiodarone-Induced Neurotoxicity." Am J Health Syst Pharm 66, no. 6 (2009): 567-9.

Winkelman, M. D., and J. D. Hines. "Cerebellar Degeneration Caused by High-Dose Cytosine Arabinoside: A Clinicopathological Study." Ann Neurol 14, no. 5 (1983): 520-7.

Wolf, P. "Acute Administration of Benzodiazepines as Part of Treatment Strategies for Epilepsy." CNS Neurosci Ther 17, no. 4 (2011): 214-20.

Woodruff, B. K., E. F. Wijdicks, and W. F. Marshall. "Reversible Metronidazole-Induced Lesions of the Cerebellar Dentate Nuclei." N Engl J Med 346, no. 1 (2002): 68-9.

Yamaguchi, I., T. Ichikawa, K. Nakao, K. Hamasaki, K. Hirano, S. Eguchi, M. Takatsuki, Y. Kawasita, T. Kanematsu, and K. Eguchi. "Cerebellar Ataxia in a Patient Receiving Calcineurin Inhibitors after Living Donor Liver Transplantation: A Case Report." Transplant Proc 39, no. 10 (2007): 3495-7.

Yamauchi, T., S. Kaneko, K. Yagi, and S. Sase. "Treatment of Partial Seizures with Gabapentin: Double-Blind, Placebo-Controlled, Parallel-Group Study." Psychiatry Clin Neurosci 60, no. 4 (2006): 507-15.

Yeshurun, M., and K. Marsot Dupuch. "Acute Cerebellar Syndrome Following Intermediate-Dose Cytarabine." Br J Haematol 113, no. 4 (2001): 846.

Zaccara, G., P. F. Gangemi, and M. Cincotta. "Central Nervous System Adverse Effects of New Antiepileptic Drugs. A Meta-Analysis of Placebo-Controlled Studies." Seizure 17, no. 5 (2008): 405-21.

Zaccara, G., F. Giovannelli, D. Maratea, V. Fadda, and A. Verrotti. "Neurological Adverse Events of New Generation Sodium Blocker Antiepileptic Drugs. Meta-Analysis of Randomized, Double-Blinded Studies with Eslicarbazepine Acetate, Lacosamide and Oxcarbazepine." Seizure 22, no. 7 (2013): 528-36.

Zaccara, G., M. Paganini, R. Campostrini, G. Arnetoli, R. Zappoli, and F. Moroni. "Hyperammonemia and Valproate-Induced Alterations of the State of Consciousness. A Report of 8 Cases." Eur Neurol 23, no. 2 (1984): 104-12.

Zaccara, G., S. M. Sisodiya, F. Giovannelli, M. C. Walker, D. C. Heaney, H. Angus-Leppan, T. Wehner, S. H. Eriksson, R. Liu, F. Rugg-Gunn, S. D. Shorvon, and J. W. Sander. "Network Meta-Analysis and the Comparison of Efficacy and Tolerability of Anti-Epileptic Drugs for Treatment of Refractory Focal Epilepsy." Br J Clin Pharmacol 76, no. 5 (2013): 827-8.

Zakrzewska, J. M., Z. Chaudhry, T. J. Nurmikko, D. W. Patton, and E. L. Mullens. "Lamotrigine (Lamictal) in Refractory Trigeminal Neuralgia: Results from a Double-Blind Placebo Controlled Crossover Trial." Pain 73, no. 2 (1997): 223-30.